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Abstract (247/ 250) 
Objective 
Pain and sleep disturbances are widespread, and are an important cause of a reduced quality 
of life. Despite this, there is a paucity of multinational population data assessing the 
association between pain and sleep problems, particularly among low- and middle-income 
countries (LMICs).  Therefore, we investigated the relationship between pain and severe 
sleep disturbance across 45 LMICs.   
Method 
Community-based data on 240,820 people recruited via the World Health Survey were 
analyzed. Multivariable logistic regression analyses adjusted for multiple confounders were 
performed to quantify the association between pain and severe sleep problems in the last 30 
days. A mediation analysis was conducted to explore potential mediators of the relationship 
between pain and severe sleep disturbance.   
Results 
The prevalence of mild, moderate, severe, and extreme levels of pain was 26.0%, 16.2%, 
9.1%, and 2.2% respectively, whilst 7.8% of adults had severe sleep problems. Compared to 
those with no pain, the odds ratio (OR, 95% CI) for severe sleep problems was 3.65 (3.24-
4.11), 9.35 (8.19-10.67) and 16.84 (13.91-20.39) for those with moderate, severe and extreme 
pain levels respectively.  A country wide meta-analysis adjusted for age and sex 
demonstrated a significant increased OR across all 45 countries.  Anxiety, depression and 
stress sensitivity explained 12.9%, 3.6%, and 5.2%, respectively, of the relationship between 
pain and severe sleep disturbances.  
Conclusion 
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Pain and sleep problems are highly co-morbid across LMICs Future research is required to 
better understand this relationship.  Moreover, future interventions are required to prevent 
and manage the pain and sleep disturbance comorbidity.   
Key words: sleep, pain, sleep disturbance, psychiatry, low- and middle-income countries 
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Introduction 
Sleep disturbance is widespread, and is a potential cause of mental and physical 
health problems as well as a reduced quality of life 1. Population cohort studies have 
demonstrated that sleep deprivation and sleep disorders affect many more people worldwide 
than previously thought 2. For example, in a large-scale community-based survey, ‘some 
insomnia problems over the past year’ were reported by more than 30% of adults, and 
chronic insomnia by about 10% 3. Furthermore, sleep problems are significant predictors of 
obesity, diabetes, stroke, coronary heart disease, widespread pain and premature mortality 4-9, 
and increase the risk for the onset of mental disorders such as depression, anxiety disorders 
and substance misuse 10-12. 
Insomnia and sleep disturbances are also a major problem to many people living with 
chronic pain 8. The worldwide chronic pain prevalence in the general adult population has 
been reported to be 30.3% with back pain, headaches and lower extremities pain being the 
most frequently reported painful ailments 13. To date, most of the research investigating the 
relationship between pain and sleep disturbances have focused on high-income countries. For 
example, in a population-based, cross-sectional telephone survey of 5001 adults aged ≥18 
years from the Hong Kong general population, the overall prevalence of people reporting 
chronic pain, sleep problems and fatigue was 5.6% (95% CI: 4.9-6.4) 14. 
Previous studies have shown that the association between sleep problems and pain 
may be bidirectional. For example, pain may cause insomnia via bodily discomfort during the 
night and lack of physical activity during the day, while insomnia may lead to pain via central 
processes that regulate pain signaling at supraspinal and spinal levels 15. Next to this, shared 
common risk factors such as physical health conditions, stress, and anxiety and depression 
have also been suggested 8. However, the degree to which the relationship between pain and 
sleep problems is influenced by psychological and psychiatric symptoms (e.g., depression, 
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anxiety, stress sensitivity) and lifestyle factors (e.g. physical activity participation) remains 
unclear. 
In addition, there is a distinct gap in the literature regarding the association between 
pain and sleep problems in representative samples of low- and middle-income countries 
(LMICs). Such data would be valuable as both conditions are highly pervasive among people 
in LMICs. For example, large multi-national studies from LMICs reported the prevalence of 
severe sleep problems to be 7.6%, ranging from 1.6% (China) to 18.6% (Morocco) 
(n=261,547 individuals aged ≥ 18 years from 56 countries) 16, while the overall age–sex 
adjusted prevalence of severe pain was 11.1%, ranging from 1.7% (China) to 31.3% 
(Morocco) (n= 235,370 individuals aged ≥ 18 years from 44 countries) 17. The association 
between pain and sleep problems in LMICs may however differ from high-income settings 
owing to factors such as differences in disease profiles which may cause pain and sleep 
problems, suboptimal treatment for physical and mental health conditions, inadequate pain 
control, and limited availability of non-pharmacologic or pharmacologic treatment for 
insomnia 2,18,19. To the best of our knowledge, only one large-scale multi-country in LMICs 
has previously investigated sleep problems and pain specifically in the elderly (≥65 years) 20. 
This study found that pain severity was a good predictor for reporting sleep complaints, with 
prevalence ratios ranging from 1.232 (95% CI = 1.02–1.48) for mild pain in the Dominican 
Republic to 4.261 (95% CI = 2.84–6.40) for unbearable pain in India. Whilst the paper 
advance the field, only eight countries (n= 16,680) were included in the analysis, data were 
not nationally-representative (only conducted within catchment sites) and it was restricted to 
older individuals.   
Given the current limitations of the literature (few association studies, often with low 
sample size & poor generalizability), this study aims to: (1) explore the relationship between 
pain and severe sleep problems across adults aged 18 and over using nationally-
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representative data from 45 LMICs; (2) investigate the factors that might influence the 
relationship between pain and severe sleep problems; and (3) conduct a country-wide meta-
analysis to explore if the association between pain and sleep problems are similar across all 
countries included in the study.  
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Methods 
The current study uses data from the World Health Survey (WHS).  The WHS is a cross-
sectional, community-based study undertaken in 2002-2004 in 70 countries worldwide. The 
details of the survey are provided elsewhere (http://www.who.int/healthinfo/survey/en/).  
Data were acquired using single-stage random sampling and stratified multi-stage random 
cluster sampling in 10 and 60 countries respectively.  People aged ≥18 years with a valid 
home address were eligible to participate. Each member of the household had equal 
probability of being selected with the use of Kish tables. Regardless of the country, data were 
collected using the same standard set of questionnaires, although some countries had a 
shorter version (and consequently less data).  In order to maximize understanding and 
comparability, the questionnaire was translated into multiple languages and was back- and 
forward-translated, and checked by linguists. Data collection was conducted either by face-
to-face interviews or via telephone by trained interviewers. The mean individual response 
rate across all countries was 98.5% 21. Sampling weights were generated to adjust for non-
response and the population distribution as reported by the United Nations Statistical 
Division 22. Ethical approval to conduct this survey was obtained from ethical boards at each 
study site. Informed consent was obtained from all participants. 
 
 Of the 69 countries for which data were publicly available, 24 countries were 
excluded for the following reasons: 10 countries (Austria, Belgium, Denmark, Germany, 
Greece, Guatemala, Italy, Netherlands, Slovenia, UK) due to lack of sampling information, 
10 high-income countries (Finland, France, Ireland, Israel, Luxembourg, Norway, Portugal, 
Spain, Sweden, United Arab Emirates) as the focus of this study was on LMICs, and 4 
countries (Congo, Mali, Slovakia, and Swaziland) as >25% of data on the main variables of 
interest (sleep and/or pain) were missing. Thus, a total of 45 countries were included in the 
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final analytical sample. According to the World Bank classification in 2003, these countries 
corresponded to 19 low-income and 26 middle-income countries. The total sample size was 
240,820. However, for some analyses, Brazil (n=5000), Hungary (n=1419), Latvia (n=929), 
Morocco (n=5000), Turkey (n=11481), or Zimbabwe (n=4290) were omitted due to missing 
data for some of the variables used in the analysis. The data were nationally-representative 
for all countries with the exception of China, Comoros, Ivory Coast, India, and Russia.  
 
Variables 
Severe sleep problems (outcome variable) 
For the purposes of the current study, severe sleep problems were assessed according to the 
question “Overall in the last 30 days, how much of a problem did you have with sleeping, 
such as falling asleep, waking up frequently during the night or waking up too early in the 
morning?”. The answer options were none, mild, moderate, severe, and extreme. Participants 
who answered severe and extreme were considered to have severe sleep problems. This 
definition has been used in previous publications using the same survey question on sleep 
problems 16,23,24. 
 
Pain (exposure variable) 
Pain was assessed in two ways. Participants were asked “Overall in the last 30 days, how 
much of bodily aches or pains did you have?” with answer options being none, mild, 
moderate, severe, and extreme. This variable was used as a categorical variable. Second, a 
continuous pain variable was constructed with the use of the above-mentioned question and 
another question “In the last 30 days, how much bodily discomfort did you have?” which also 
had the same response options. A factor analysis with polychoric correlations was used in 
order to obtain a factor score which was converted into a scale ranging from 0 to 10 with 
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higher scores corresponding to higher levels of pain/discomfort. These pain scores have 
previously been used in papers from the WHS 25,26. 
 
Control variables 
The control variables were selected based on past literature 16,17, and included sex, age, 
highest educational level achieved (no formal education, primary education, secondary or 
high school completed, or tertiary education completed), wealth, setting (rural/urban), current 
smoking, alcohol consumption, and physical diseases. Principal component analysis based on 
15-20 assets was performed to establish country-wise wealth quintiles. The question on 
smoking was ‘Do you currently smoke any tobacco products such as cigarettes, cigars, or 
pipes?’ with the answer options being ‘daily’, ‘yes, but not daily’, or ‘no, not at all’. This 
variable was dichotomized into those who smoked regardless of frequency (i.e., daily or not 
daily) (current smokers) and those who do not smoke. Alcohol consumption was assessed by 
first asking the question ‘Have you ever consumed a drink that contains alcohol (such as 
beer, wine, etc)?’ Respondents who replied ‘no’ were considered lifetime abstainers. If the 
respondent replied affirmatively, then he/she was asked how many standard drinks of any 
alcoholic beverage he/she had on each day of the past 7 days. The number of days in the past 
week in which 4 (female) or 5 (male) drinks were consumed was calculated, and a total of 1-
2 and ≥3 days in the past 7 days were considered infrequent and frequent heavy drinking 
respectively. All other respondents, apart from lifetime abstainers, were considered non-
heavy drinkers 16. Arthritis, asthma, and diabetes were based solely on self-reported lifetime 
diagnosis. For angina, in addition to a self-reported diagnosis, a symptom-based diagnosis 
based on the Rose questionnaire was also used 27. Chronic back pain was defined as having 
had back pain (including disc problems) every day during the last 30 days. The total number 
of these conditions was calculated. Data on education was missing from Turkey. 
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Mediators 
The mediators in the association between pain and severe sleep problems which were 
considered included depression, anxiety, stress sensitivity, and low physical activity. This 
was based on past literature pointing to pain leading to these conditions, which in turn, may 
lead to sleep problems 28-30. The presence of depression based on the duration and persistence 
of depressive symptoms in the previous 12 months was established using DSM-IV criteria 16. 
Anxiety was assessed by the question “Overall in the past 30 days, how much of a problem 
did you have with worry or anxiety?” Respondents could answer: none, mild, moderate, 
severe, or extreme. For the purposes of the current study, participants who answered severe 
and extreme were categorized as having anxiety 16,31. Stress sensitivity in the last month was 
assessed by two questions: “How often have you felt that you were unable to control the 
important things in your life?”; and “How often have you found that you could not cope with 
all the things that you had to do?” The answer options to these questions were: never 
(score=1), almost never (score=2), sometimes (score=3), fairly often (score=4), very often 
(score=5). The scores of the two questions were added to create a scale ranging from 2 to 10 
32. The short form of the International Physical Activity Questionnaire was used to assess the 
level of physical activity using conventional cut-offs (low, moderate, high) 33. This was 
dichotomized as low physical activity or else (moderate and high) 34. Data on depression and 
anxiety were missing from Turkey and Morocco respectively. Furthermore, there was no data 
on stress sensitivity from Brazil, Hungary, Turkey, and Zimbabwe, while Latvia and 
Morocco had no data on physical activity. 
 
Statistical analysis 
The statistical analysis was performed with Stata 14.1 (Stata Corp LP, College station, 
Texas). Descriptive analysis was performed to illustrate sample characteristics across 
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different levels of pain. Chi-squared tests and one-way ANOVA were used to assess the 
difference between sample characteristics by different pain levels for categorical and 
continuous variables respectively. Using the overall sample, multivariable logistic regression 
analysis was conducted to assess the association between pain (exposure variable) and severe 
sleep problems (outcome variable). Two different pain measures (mentioned above) were 
used and were included individually in the models. Stratified analyses by sex and age groups 
(18-44, 45-64, ≥65 years) were also conducted. The models were adjusted for sex, age, 
education, wealth, setting, current smoking, alcohol consumption, physical diseases, and 
country, with the exception of the sex-stratified models which were not adjusted for sex. A 
test for trend was performed by including the categorical pain variable as a continuous 
variable in the models.  
 Next, a mediational analysis was conducted to understand the extent to which the 
association between pain and severe sleep problems can be explained by the hypothesized 
mediators (depression, anxiety, stress sensitivity, low physical activity). The khb (Karlson 
Holm Breen) command in Stata 35 was used  for this purpose. This method, which can be 
used with logistic regression models, has been widely applied in mental health research 36, 
and decomposes the total effect into direct and indirect effects. This method also allows for 
the calculation of the mediated percentage (percentage of the main association that can be 
explained by the mediator). Each potential mediator was included in the models separately, 
and the models were adjusted for sex, age, education, wealth, setting, current smoking, 
alcohol consumption, physical diseases, and country.  
 Finally, in order to assess the generalizability of the findings based on the pooled 
sample across all countries, we conducted country-wise logistic regression analyses for the 
association between the pain score and severe sleep problems while adjusting for age and sex. 
A pooled estimate was obtained by meta-analysis with random effects. For all regression 
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analyses, the variables were included in the models as categorical variables with the 
exception of age, pain score, stress sensitivity, and number of physical diseases (continuous 
variables). Adjustment for country was done by including dummy variables for each country 
as in previous WHS publications 16,21. The sample weighting and the complex study design 
were taken into account in all analyses. Results from the logistic regression models are 
presented as odds ratios (ORs) with 95% confidence intervals (CIs). The level of statistical 
significance was set at P<0.05.  
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Results 
The mean (SD) age of the sample was 38.4 (16.0) years with 50.7% being females (Table 1). 
Overall, the prevalence of mild, moderate, severe, and extreme levels of pain were 26.0%, 
16.2%, 9.1%, and 2.2% respectively, whilst 7.8% of the sample had severe sleep problems. 
Higher levels of pain were associated with female sex, advanced age, lower levels of 
education and wealth, current smoking, lifetime abstention from alcohol, greater number of 
physical diseases, depression, anxiety, higher levels of stress sensitivity, and low physical 
activity. The prevalence of severe sleep problems increased linearly with increasing levels of 
pain for all age groups, with a particularly high prevalence of severe sleep problems in the 
oldest age group for extreme pain (66.5%) (Figure 1). The distribution of pain levels in each 
of the sleep categories are shown in eTable 1 of the Appendix. 
Table 1 here 
Figure 1 here 
Relationship between pain and severe sleep problems 
The association between pain and severe sleep problems estimated by multivariable logistic 
regression is shown in Table 2. Based on the categorical pain variable, there was a dose-
dependent incremental odds for severe sleep problems with increasing levels of pain. In the 
overall sample, compared to those with no pain, the OR (95%CI) for severe sleep problems 
for those with extreme pain was 16.84 (13.91-20.39). Estimates based on the continuous pain 
score also showed similar trends with a one-unit increase in the pain score (range 0-10) being 
associated with 1.43 times higher odds for severe sleep problems in the overall sample. For 
both pain variables, the association between severe sleep problems was similar across 
females and males. In terms of age groups, a stronger association was observed for younger 
age groups.  
Table 2 here 
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Mediators of pain and severe sleep problem relationship 
Next, for all the mediators assessed, the indirect effect was significant (Table 3). However, 
apart from anxiety (12.9%), only a small proportion of the association between pain and 
severe sleep problems was explained by these mediators: depression (3.6%), stress sensitivity 
(5.2%), and low physical activity (0.6%).  
Table 3 
Meta-analysis of pain and severe sleep problems 
Finally, the country-wise analysis showed that the pain score (range 0-10) is significantly and 
positively associated with severe sleep problems in all the countries studied with the OR 
(95%CI) ranging from 1.20 (1.07-1.34) in Senegal to 2.05 (1.72-2.45) in Pakistan. The 
pooled estimate based on a meta-analysis was 1.51 (95%CI=1.47-1.55). These ORs can be 
interpreted as the change in ORs associated with a one-unit increase in the pain score. The 
pooled estimates in low-income countries and middle-income countries were 1.53 
(95%CI=1.45-1.61) and 1.50 (95%CI=1.45-1.54), respectively. Every country included in the 
meta-analysis established that increasing levels of pain was associated with severe sleep 
disturbance.   
Figure 2 here 
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Discussion 
General findings 
To the best of our knowledge the current study is the first to explore on a multi-national level, 
the relationship between pain and severe sleep problems in adults aged 18 and over. Our data 
show that compared to those with no pain, those with extreme pain had a more than 16-fold 
increased risk (OR=16.84; 95%CI=13.91-20.39) for severe sleep problems. Moreover, our 
data suggest that as pain severity increases, an incremental increase odds in severe sleep 
problems was also evident. Our meta-analysis across 45 countries adjusted for age and sex 
demonstrated that the relationship between increasing levels of pain and severe sleep 
problems is consistent across all countries. While anxiety appears to account for a reasonable 
proportion of (mediation of 12.9%) increased severe sleep problems, the potential 
contribution of depression (3.6%), stress sensitivity (5.2%), and low physical activity (0.6%) 
appears to be minimal.  However, these factors only explain a small amount of this 
relationship and it may be that other factors not measured in our study contribute to this 
relationship.   
 
The current data clearly show a strong relation between pain and severe sleep 
problems. Although the current study was cross-sectional, it might be hypothesized that pain 
and sleep disturbances mutually reinforce each other. The mechanisms contributing to the 
sleep-pain relationship are however poorly understood. Several hypotheses have been 
formulated to explain the possible underlying mechanisms.  First, sleep disturbances disrupt 
pain modulation – central processes that regulate pain signaling (nociception) at supraspinal 
and spinal levels 15. As also emotion circuits are highly interconnected with pain modulation 
circuitries, emotions can up- and down-regulate pain and spinal nociception 37 while 
emotional arousal due to sleep problems on its turn may compound the problem 38. Indeed, 
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this is consistent with our finding that the link between pain and sleep was partially mediated 
by anxiety. Second, pain medication might disrupt the sleep–wake cycle 39. Clearly more 
research is required to better understand the relationship and in particular establish 
directionality and underpinning mechanisms.   
 
Whilst we noted that there was a consistent relationship between pain and severe sleep 
problems across both low and middle income countries, both collectively and individually, 
there was some variation.  For instance, in low income countries, a notably high odds ratio 
was noted in Pakistan, Laos, Myanmar and Vietnam. ).  Similarly, high levels of comorbidity 
of pain and severe sleep problems were noted in middle income countries China and 
Malaysia There is very little published evidence on the association between severe sleep and 
pain problems in LMICs. Therefore, any explanation across countries currently is highly 
speculative. Country-related differences are however intriguing and may hold clues to the 
etiology of severe sleep and pain problems and their treatment across different settings, and 
certainly warrant further research. When comparing the odds between low and middle 
income countries, we can speculate that differences cannot be entirely explained by 
poverty. Potential hypotheses could include differences in access to sleep and pain 
management (including access to analgesic and sleep medication or non-pharmacological 
interventions such as physiotherapy40. Next this, also differences in a variety of sociocultural 
factors, from traditional and religious beliefs towards pain and sleep problems to local 
preferences for sleep and pain management may influence country-wise disparities in the 
association of pain with severe sleep problems 41. 
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Our data demonstrates that sleep problems are an important problem in people experiencing 
pain in LMICs. More research to understand the underlying mechanisms for this relationship 
is urgently needed. However, even before more rigorous evidence is available, clinicians in 
practice should be alerted to this high level of association. For example, future research 
should explore whether systematically integrating sleep assessment, in the clinical practice 
guidelines for people experiencing acute or chronic pain and vice versa systematically 
integrating pain assessments in those experiencing severe sleep problems might reduce the 
co-morbid burden of severe sleep or pain problems.  However, effective sleep and pain 
monitoring will not be not sufficient on its own, as appropriate treatment is also mandatory. 
Pharmacotherapy of sleep disturbances due to acute or chronic pain has however received 
very little attention. To date, several drug classes have been evaluated, and no consensus on 
treating disturbed sleep in acute or chronic pain has arisen 39. In resource-limited settings, 
many of the medication used in developed country settings may also not be available 30. 
There are, to the best of our knowledge, currently also no evidence-based treatment 
algorithms for comorbid pain and sleep problems. However, a recent meta-analysis 43 
indicated that non-pharmacological sleep treatments (including physiotherapy, exercise, 
yoga, qigong, mindfulness meditation, massage, and cognitive behavioral therapy involving 
psychoeducation, sleep hygiene, stimulus control therapy, sleep restriction therapy, sleep 
scheduling, relaxation, paradoxical intention, and imagery exercises) in chronic pain patients 
were associated with a large improvement in sleep quality (standardized mean difference = 
0.78; 95%CI=0.42 to 1.13, P< 0.001) and a small reduction in pain (SMD=0.18, 95%CI=0 to 
0.36, P<0.05) post-treatment. The effects on sleep quality were maintained at follow-up (up 
to 1 year) when a moderate reduction in depression (SMD=0.31; 95%CI=0.09 to 0.53, 
P<0.01) was also observed. However, although efficacious in high-income countries, 
research regarding the effectiveness of these non-pharmacological treatments, including a 
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cost-effectiveness analysis, in LMICs is urgently needed before any of these therapies can be 
recommended. 
 
Study limitations 
Current findings should be interpreted in the light of some limitations. First of all, the 
severity and duration of pain and severe sleep problems could not be assessed due to lack of 
data. Therefore, we were unable to undertake more detailed analyses related to the type or 
chronicity of participants' sleep problems which might have helped further elucidate the 
association between severe sleep problems and pain. Second, the study was cross-sectional, 
therefore cause and effect between pain and severe sleep problems cannot be deduced with 
certainty.  Clearly, future longitudinal research is required to further explore the potential 
directionality of the outcomes we observed.  Third, we did not have information on 
medication use such as hypnotics or analgesic medication which may have influenced our 
data.  Future research should consider the impact of such medications and other non-
pharmacological interventions (e.g. exercise) and how this influences the relationship 
between pain and severe sleep problems.   
 In conclusion, our study suggests that pain is associated with substantially increased 
odds of severe sleep problems.  Our data also suggests that severe sleep problems are 
incrementally increased with pain severity and that mood (in particular anxiety and 
depression) may partially mediate this relationship.  Given the highly comorbid and pervasive 
nature of pain and sleep disturbance, future research is required to further understand these 
relationships and population level interventions are needed to address this common problem.   
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Table 1 Sample characteristics by different levels of pain 
      
Overall in the last 30 days, how much of bodily aches or pains did you 
have? 
Characteristic   Overall  None Mild Moderate Severe Extreme 
Sex  Male 49.3 56.6 47.6 41.2 35.2 31.1 
 
Female 50.7 43.4 52.4 58.8 64.8 68.9 
Age (years) Mean (SD) 38.4 (16.0) 34.0 (14.0) 39.3 (15.3) 43.5 (17.1) 47.0 (17.2) 47.3 (15.5) 
Educationa No formal 26.2 21.4 27.1 29.9 38.7 39.5 
 
≤Primary 31.0 28.8 31.8 33.5 33.5 37.6 
 
Secondary completed 33.6 39.2 31.8 28.7 22.2 18.0 
 
Tertiary completed 9.2 10.6 9.3 7.8 5.6 4.9 
Wealth Poorest 20.1 17.9 19.9 23.0 25.7 25.5 
 
Poorer 20.0 19.0 19.9 21.9 22.6 20.5 
 
Middle 20.0 20.3 19.9 19.5 19.6 20.1 
 
Richer 19.9 20.3 21.0 18.3 17.7 18.9 
 
Richest 20.0 22.6 19.4 17.4 14.4 15.0 
Setting Urban 44.5 45.7 42.7 46.2 40.2 43.2 
Current smoking No 73.0 74.3 72.0 72.6 70.9 70.4 
 
Yes 27.0 25.7 28.0 27.4 29.1 29.6 
Alcohol consumption Lifetime abstainer 66.9 67.3 66.9 64.2 68.6 71.3 
 
Non-heavy 28.4 27.6 28.3 31.4 28.3 25.7 
 
Infrequent heavy 3.6 3.9 3.9 3.4 2.3 2.3 
 
Frequent heavy 1.0 1.1 0.9 1.1 0.8 0.6 
No. of physical diseasesa Mean (SD) 0.42 (0.74) 0.18 (0.47) 0.42 (0.67) 0.70 (0.86) 1.05 (0.99) 1.22 (0.83) 
Depressiona No 93.0 97.4 94.2 88.4 79.5 69.7 
 
Yes 7.0 2.6 5.8 11.6 20.5 30.3 
Anxietyb No 88.4 94.4 91.1 84.3 65.3 50.4 
 
Yes 11.6 5.6 8.9 15.7 34.7 49.6 
Stress sensitivityc Mean (SD) 4.8 (2.2) 4.3 (2.1) 5.0 (2.0) 5.4 (2.1) 5.9 (2.2) 6.4 (1.9) 
Low physical activityd No 82.7 85.7 84.0 80.0 71.5 63.6 
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  Yes 17.3 14.3 16.0 20.0 28.5 36.4 
Estimates are based on weighted sample. Data are column % with the exception of age and stress sensitivity [mean (SD)]. 
Data are from 45 countries unless otherwise stated. 
a 44 countries (Turkey is not included). 
b 44 countries (Morocco is not included). 
c 41 countries (Brazil, Hungary, Turkey, and Zimbabwe are not included). Scale ranges from 2-10 with higher scores indicating higher levels of stress sensitivity.  
d 43 countries (Latvia and Morocco are not included). 
All overall differences in sample characteristics by different levels of pain are statistically significant (p<0.0001). 
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Table 2 Association between pain and severe sleep problems (outcome) estimated by multivariable logistic regression 
  Overall Female Male Age 18-44 years Age 45-64 years Age ≥65 years 
  OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI 
(a) Overall in the last 30 days, how much of bodily aches or pains did you have?a 
None 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
Mild 1.72** [1.51,1.95] 1.59** [1.33,1.89] 1.86** [1.54,2.24] 2.01** [1.70,2.37] 1.38* [1.10,1.74] 0.96 [0.69,1.35] 
Moderate 3.65** [3.24,4.11] 3.32** [2.83,3.89] 4.08** [3.39,4.91] 4.19** [3.57,4.92] 3.19** [2.56,3.98] 1.95** [1.42,2.66] 
Severe 9.35** [8.19,10.67] 8.80** [7.40,10.46] 9.75** [7.85,12.11] 10.72** [8.95,12.83] 7.94** [6.31,9.99] 5.23** [3.79,7.23] 
Extreme 16.84** [13.91,20.39] 16.87** [13.33,21.35] 15.41** [11.11,21.38] 17.88** [13.92,22.97] 13.10** [9.08,18.90] 13.48** [8.42,21.56] 
(b) Pain score (range 0-10)b 1.43** [1.40,1.45] 1.43** [1.40,1.46] 1.42** [1.38,1.46] 1.43** [1.40,1.47] 1.41** [1.36,1.46] 1.40** [1.33,1.48] 
Abbreviation: OR odds ratio; CI confidence interval 
All models are adjusted for sex, age, education, wealth, setting, current smoking, alcohol consumption, physical diseases, and country with the exception of models restricted to females or 
males which are not adjusted for sex. 
The two pain variables [i.e., (a) and (b)] were included separately in the models. 
A total of 44 countries were included in the analysis. Turkey was not included as no information on education was available. 
a Significant test for trend for all models (p<0.0001). 
b Higher scores on the pain scale indicate more severe pain. 
* p<0.01, ** p<0.001 
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Table 3 Depression, anxiety, stress sensitivity, and low physical activity as 
mediators in the association between pain score and severe sleep problems 
Mediator Effect OR (95%CI) P-value 
% 
Mediated 
Depressiona Total 1.43 (1.41-1.46) <0.0001 3.6 
 
Direct 1.41 (1.39-1.44) <0.0001 
 
 
Indirect 1.01 (1.01-1.02) <0.0001 
 
Anxietyb Total 1.40 (1.37-1.42) <0.0001 12.9 
 
Direct 1.34 (1.31-1.37) <0.0001 
 
 
Indirect 1.04 (1.04-1.05) <0.0001 
 
Stress sensitivityc Total 1.47 (1.43-1.50) <0.0001 5.2 
 
Direct 1.44 (1.41-1.47) <0.0001 
 
 
Indirect 1.02 (1.02-1.02) <0.0001 
 
Low physical activityd Total 1.42 (1.40-1.45) <0.0001 0.6 
 
Direct 1.42 (1.39-1.45) <0.0001 
 
  Indirect 1.002 (1.0008-1.003) 0.0017   
Abbreviation: OR Odds Ratio; CI Confidence Interval 
Models are adjusted for sex, age, education, wealth, setting, current smoking, alcohol consumption, physical 
diseases, and country. 
a Includes 44 countries (Turkey is not included) 
b Includes 43 countries (Morocco and Turkey are not included) 
c Includes 41 countries (Brazil, Hungary, Turkey, and Zimbabwe are not included) 
d Includes 42 countries (Latvia, Morocco, and Turkey are not included) 
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Figure 1 Prevalence of severe sleep problems by level of pain and age group 
Data is based on weighted sample from 45 countries. 
The question used to assess level of pain was “Overall in the last 30 days, how much of bodily aches or pains 
did you have?” 
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Figure 2 Country-wise association between pain score and severe sleep problems 
(outcome) estimated by age- and sex-adjusted logistic regression in 45 countries 
Abbreviation: OR odds ratio; CI confidence interval 
The pain score ranged from 0-10 with higher scores corresponding to higher levels of pain. 
Overall estimate was obtained by meta-analysis with random effects. 
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